Table 2.
Design of simulation 3 for evaluation
Gene ID | Treatment Group | Control Group |
1 | Exon 5~N (0, 1) | All exons ~N (1.5,1), correlated |
Exon 6~N (0, 1) | ||
Others ~N (2.5, 1), correlated | ||
2 | Exon 5~N (0, 1) | All exons ~N (2.5,1), correlated |
Exon 6~N (0, 1) | ||
Others ~N (1.5, 1), correlated | ||
3 | Exon 5~N (2.5, 1) | Exon 5~N (0, 1) |
Exon 6~N (0, 1) | Exon 6~N (1.5, 1) | |
Others ~N (2.5, 1), correlated | Others ~N (1.5, 1), correlated | |
4 | Exon 5~N (1.5, 1) | Exon 5~N (0, 1) |
Exon 6~N (0, 1) | Exon 6~N (2.5, 1) | |
Others ~N (1.5, 1), correlated | Others ~N (2.5, 1), correlated |
The design of alternatively spliced exons is same with simulation 1, but the power of normal distribution is different between two sample groups to simulate the differential expression in gene level.